Home: PCU 3|2003: Anthony L Zietman, MD, FRCR: Select publications

Select publications

Publications discussed by Dr Zietman

Holmberg L et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347(11):781-9. Abstract

Widmark A et al. Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology 2003;61(1):145-51. Abstract

Zietman AL et al. Conservative management of prostate cancer in the prostate specific antigen era: The incidence and time course of subsequent therapy. J Urol 2001;166(5):1702-6. Abstract

Watchful waiting

Bacon CG et al. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 2001;166(5):1804-10. Abstract

Chapple A et al. Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study. BJU Int 2002;90(3):257-64. Abstract

Choo R et al. Feasibility study: Watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 2002;167(4):1664-9. Abstract

Schmid HP et al. Active monitoring (deferred treatment or watchful waiting) in the treatment of prostate cancer. A review. Eur Urol 2001;40(5):488-94. Abstract

Schwartz E, Albertsen P. Nomograms for clinically localized disease. Part III: Watchful waiting. Semin Urol Oncol 2002;20(2):140-5. Abstract

Wilt TJ, Brawer MK. The Prostate Cancer Intervention Versus Observation Trial (PIVOT). Oncology (Huntingt) 1997;11(8):1133-9;discussion 1139-40, 1143. Abstract

 

 
   

Home

Editor’s Note

Laurence Klotz, MD, FRCSC
    - Select publications

Paul F Schellhammer, MD
    - Select publications

Anthony L Zietman, MD, FRCR
    - Select publications

 

Editor's Office

 
Terms of use and general disclaimer
© NL Communications, Inc. 2002. All rights reserved.